EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN VCA IgG Test
Test Name: EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN VCA IgG Test
Components: 2 mL (1 mL min.) serum from 1 SST
Price: 370.0 AED
Sample Condition: Ship refrigerated or frozen
Report Delivery: SampleSat by 9 am; Report Same day
Method: Enzyme Immunoassay
Test type: Infections
Doctor: Physician
Test Department: Pre Test Information
No special preparation required
The Epstein-Barr virus (EBV) antibody to viral capsid antigen (VCA) IgG test is a blood test used to detect antibodies produced by the immune system in response to an EBV infection. EBV is a common virus that causes infectious mononucleosis, also known as “mono” or the “kissing disease.” The virus is spread through saliva and can cause symptoms such as fatigue, sore throat, fever, swollen lymph nodes, and enlarged spleen.
The VCA IgG test specifically detects the presence of IgG antibodies against the viral capsid antigen of the EBV. IgG antibodies are produced by the immune system after an initial infection and remain in the body for a long time, providing immunity against future infections. A positive VCA IgG test result indicates that a person has been infected with EBV at some point in their life and has developed immunity to the virus. It does not necessarily mean that the person is currently infected or experiencing symptoms.
The VCA IgG test is commonly used in diagnosing past or recent EBV infections, especially when symptoms are present. It can also be used to determine if a person has had previous exposure to EBV, which can be helpful in certain medical situations or for epidemiological studies. It is important to note that the VCA IgG test alone cannot differentiate between a recent or past infection. Additional tests, such as the EBV nuclear antigen (EBNA) IgG test, may be needed to determine the stage of infection or if the infection is currently active.
Overall, the VCA IgG test is a valuable tool in diagnosing and monitoring EBV infections, providing important information about a person’s immune response to the virus.
Test Name | EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN VCA IgG Test |
---|---|
Components | |
Price | 370.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
Report Delivery | SampleSat by 9 am; Report Same day |
Method | Enzyme Immunoassay |
Test type | Infections |
Doctor | Physician |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The Epstein-Barr virus (EBV) antibody to viral capsid antigen (VCA) IgG test is a blood test used to detect antibodies produced by the immune system in response to an EBV infection. EBV is a common virus that causes infectious mononucleosis, also known as “mono” or the “kissing disease.” The virus is spread through saliva and can cause symptoms such as fatigue, sore throat, fever, swollen lymph nodes, and enlarged spleen. The VCA IgG test specifically detects the presence of IgG antibodies against the viral capsid antigen of the EBV. IgG antibodies are produced by the immune system after an initial infection and remain in the body for a long time, providing immunity against future infections. A positive VCA IgG test result indicates that a person has been infected with EBV at some point in their life and has developed immunity to the virus. It does not necessarily mean that the person is currently infected or experiencing symptoms. The VCA IgG test is commonly used in diagnosing past or recent EBV infections, especially when symptoms are present. It can also be used to determine if a person has had previous exposure to EBV, which can be helpful in certain medical situations or for epidemiological studies. It is important to note that the VCA IgG test alone cannot differentiate between a recent or past infection. Additional tests, such as the EBV nuclear antigen (EBNA) IgG test, may be needed to determine the stage of infection or if the infection is currently active. Overall, the VCA IgG test is a valuable tool in diagnosing and monitoring EBV infections, providing important information about a person’s immune response to the virus. |